DE1670524A1 - Darstellung von 5-Hydroxy-6-methyl-cinchomeronitril und Zwischenprodukte dafuer - Google Patents

Darstellung von 5-Hydroxy-6-methyl-cinchomeronitril und Zwischenprodukte dafuer

Info

Publication number
DE1670524A1
DE1670524A1 DE19661670524 DE1670524A DE1670524A1 DE 1670524 A1 DE1670524 A1 DE 1670524A1 DE 19661670524 DE19661670524 DE 19661670524 DE 1670524 A DE1670524 A DE 1670524A DE 1670524 A1 DE1670524 A1 DE 1670524A1
Authority
DE
Germany
Prior art keywords
alkoxy
molecular weight
low molecular
reaction
oxazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661670524
Other languages
German (de)
English (en)
Inventor
Takeo Naito
Yoshiaki Omura
Toru Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4746365A external-priority patent/JPS4811713B1/ja
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE1670524A1 publication Critical patent/DE1670524A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19661670524 1965-05-21 1966-05-20 Darstellung von 5-Hydroxy-6-methyl-cinchomeronitril und Zwischenprodukte dafuer Pending DE1670524A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2959265 1965-05-21
JP4746365A JPS4811713B1 (cg-RX-API-DMAC7.html) 1965-08-06 1965-08-06
JP7481565 1965-12-07

Publications (1)

Publication Number Publication Date
DE1670524A1 true DE1670524A1 (de) 1972-04-20

Family

ID=27286643

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661670524 Pending DE1670524A1 (de) 1965-05-21 1966-05-20 Darstellung von 5-Hydroxy-6-methyl-cinchomeronitril und Zwischenprodukte dafuer

Country Status (4)

Country Link
CH (2) CH456595A (cg-RX-API-DMAC7.html)
DE (1) DE1670524A1 (cg-RX-API-DMAC7.html)
GB (2) GB1123229A (cg-RX-API-DMAC7.html)
NL (1) NL6607005A (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
GB1123230A (en) 1968-08-14
CH464919A (fr) 1968-11-15
GB1123229A (en) 1968-08-14
NL6607005A (cg-RX-API-DMAC7.html) 1966-11-22
CH456595A (fr) 1968-07-31

Similar Documents

Publication Publication Date Title
DE2849224C2 (de) 1,9-Dihydroxyoctahydrophenanthrene, 1-Hydroxyoctahydrophenanthren-9-one, 1-Hydroxyhexahydrophenanthren-9-one sowie Derivate hiervon und Zwischenprodukte zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1620694B2 (de) Verfahren zur Herstellung von 5-Methyl-7-diäthylamino-s-triazolo [1,5-a] pyrimidin und seinen Salzen mit Säuren
DE2065961C2 (de) Verfahren zur Herstellung von Dijodmethylsulfonen
DE1670524A1 (de) Darstellung von 5-Hydroxy-6-methyl-cinchomeronitril und Zwischenprodukte dafuer
DE1670248C3 (de) Verfahren zur Herstellung von 4-Isothiazolcarbonsäuren
DE1104965B (de) Verfahren zur Herstellung von Derivaten des Urazols
EP0091044B1 (de) Verfahren zur Herstellung von 4-Hydroxy-3-(heterocyclocarbamoyl)-2H-1,2-benzothiazin-1,1-dioxiden
DE2705414A1 (de) 1-hydrazinophthalazine, ihre salze mit saeuren, verfahren zu ihrer herstellung und arzneimittel
DE1078582B (de) Verfahren zur Herstellung substituierter Thyropropionsaeuren
EP0275470A1 (de) N-substituierte, Estergruppen enthaltende Acrylamide
DE2111610C3 (de) Verfahren zur Herstellung von Salzen von Pyrimidyl-pyridiniumderivaten
DE2033090C3 (de) deren Herstellung
DE821524C (de) Verfahren zur Herstellung von Benzimidazol-Netrocyaninen
DE1770177A1 (de) Monoaryl-substituierte Oxazole
DE1954839A1 (de) Tetrazolderivate
DE940897C (de) Verfahren zur Herstellung der threo-Formen von Oxazolinen
DE1745780C3 (de) l-Sulfonyläthyl^-methyl-S-nitroimidazole und Verfahren zu ihrer Herstellung
CH653013A5 (de) Verfahren zur herstellung von dialkyl-(n-cyanimido)-carbonaten.
DE2832977C2 (cg-RX-API-DMAC7.html)
DE1929237A1 (de) Verfahren zur Herstellung von N-Acyl-3,4-epoxy-pyrrolidin-Derivaten
DE3918122A1 (de) Verfahren zur herstellung von 3-(amino)-crotonsaeuremethylester
DE912221C (de) Verfahren zur Herstellung von curareaehnlich wirkenden quaternaeren Salzen
DE1470291A1 (de) Verfahren zur Herstellung von Thiamin-Derivaten vom im O,S-disubstituierten Thiol-Typus
DE1044102B (de) Verfahren zur Herstellung von Estern der Xanthen-9-carbonsaeure
DE1543295A1 (de) Verfahren zur Herstellung N-substituierter Anthranilsaeuren und ihrer Salze